title: Allopurinol inhibits hypoxic pulmonary vasoconstriction. Role of toxic oxygen metabolites.
abstract: The exact mechanism whereby hypoxic pulmonary vasoconstriction (HPV) is elicited is still unsettled. We have evaluated a possible role for toxic oxygen metabolites (TOM), employing a set-up of blood-perfused isolated rat lungs. HPV reflected as pulmonary arterial pressor responses, was evoked by alternately challenging the airways with a hypoxic- and a normoxic gas mixture, resulting in gradually increasing responses until a maximum was obtained. In a sequence of responses (mean +/- s.e. mean) increasing from 2.5 +/- 0.2 kPa to 3.2 +/- 0.1 kPa, administration to the perfusate of the inhibitor of xanthine oxidase (XO), allopurinol (AP) reduced the subsequent response to 2.5 +/- 0.2 kPa (P less than 0.001). By contrast, AP did not affect vasoconstriction induced by serotonin or bradykinin. In control experiments responses continued to increase after administration of hypoxanthine (substrate of XO). Neither pretreatment with daily injections of the antioxidant vitamin E for 3 days in advance, nor addition to the perfusate of the scavenger enzymes superoxide dismutase and catalase, or dimethylsulfoxide had any impact on HPV; the subsequent responses rose at the same rate and in the same way as before. Thus, the present study has shown that AP inhibition of XO depresses HPV. This could be due either to reduced production of TOM or to accumulation of purine metabolites. The absence of inhibitory effects of quenchers of TOM refutes a role for these metabolites in the elicitation of HPV. More likely, AP inhibits HPV by interfering with the purine metabolism.
authors.affiliation: Department of Anesthesiology, University of Tromsø, Norway.
authors.forename: J
authors.initials: J
authors.lastname: Kjaeve
authors.forename: T
authors.initials: T
authors.lastname: Veel
authors.forename: L
authors.initials: L
authors.lastname: Bjertnaes
mesh_terms: D000493:Allopurinol / Q000494:pharmacology*; D000818:Animals; D002374:Catalase / Q000494:pharmacology; D000860:Hypoxia / Q000503:physiopathology*; D066298:In Vitro Techniques; D008168:Lung / Q000098:blood supply*; D008297:Male; D010100:Oxygen / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013482:Superoxide Dismutase / Q000494:pharmacology; D014118:Toxins, Biological; D014661:Vasoconstriction / Q000187:drug effects*; D014810:Vitamin E / Q000494:pharmacology
chemical_list: D014118:Toxins, Biological; D014810:Vitamin E; D000493:Allopurinol; D002374:Catalase; D013482:Superoxide Dismutase; D010100:Oxygen